학술논문
Rituximab, bendamustine, and low-dose cytarabine as induction therapy in elderly patients with mantle cell lymphoma: a multicentre, phase 2 trial from Fondazione Italiana Linfomi
Document Type
Article
Author
Visco, C.; Ruggeri, M.; Chiappella, A.; Vitolo, U.; Nassi, L.; Gaidano, G.; Patti, C.; Ferrero, S.; Barbero, D.; Evangelista, A.; Ciccone, G.; Spina, M.; Molinari, A.; Rigacci, L.; Tani, M.; Rocco, A.D.; Martelli, M.; Pinotti, G.; Fabbri, A.; Zambello, R.; Finotto, S.; Gotti, M.; Carella, A.M.; Salvi, F.; Ladetto, M.; Pileri, S.A.
Source
In: The Lancet Haematology . (The Lancet Haematology, 1 January 2017, 4(1):e15-e23)
Subject
Language
English
ISSN
23523026